Switch to:
More From Other Websites
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Sep 15 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer Sep 15 2014
Antares Pharma to Participate at the Morgan Stanley Healthcare Conference Sep 03 2014
ANTARES PHARMA, INC. Financials Aug 15 2014
Q2 2014 Antares Pharma, Inc. Earnings Release - Before Market Open Aug 07 2014
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Aug 07 2014
Antares Pharma Reports Second Quarter 2014 Operating and Financial Results Aug 07 2014
Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call Jul 31 2014
ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 22 2014
Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot Study Evaluating... Jul 22 2014
ANTARES PHARMA, INC. Files SEC form 8-K, Other Events Jul 11 2014
Antares: Uncertainty Creates An Exceptional Buying Opportunity Jul 08 2014
Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved with Once-Weekly... Jun 25 2014
Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% Jun 25 2014
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 24 2014
Antares Pharma Announces Changes in Senior Leadership Jun 24 2014
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 04 2014
Otrexup Sales Trajectory Points To First Profitable Quarter For Antares Pharma In 2015 May 28 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK